Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3299611013 | Oral form ombitasvir + paritaprevir + ritonavir | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
3299843010 | Oral form ombitasvir + paritaprevir + ritonavir (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
3488637018 | Product containing ombitasvir and paritaprevir and ritonavir in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
3497762010 | Product containing ombitasvir and paritaprevir and ritonavir in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
3497763017 | Ombitasvir and paritaprevir and ritonavir in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
3711092016 | Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3711093014 | Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Is a | Ritonavir-containing product in oral dose form | true | Inferred relationship | Some | ||
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Is a | Ombitasvir- and paritaprevir- and ritonavir-containing product | true | Inferred relationship | Some | ||
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Is a | Paritaprevir-containing product in oral dose form | true | Inferred relationship | Some | ||
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Is a | Ombitasvir-containing product in oral dose form | true | Inferred relationship | Some | ||
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Has active ingredient | Ritonavir | true | Inferred relationship | Some | 1 | |
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Has active ingredient | Ombitasvir | true | Inferred relationship | Some | 2 | |
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Has active ingredient | Paritaprevir | true | Inferred relationship | Some | 3 | |
Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ombitasvir and paritaprevir and ritonavir only product in oral dose form | Is a | True | Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Inferred relationship | Some | |
Dasabuvir- and ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Is a | True | Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets